Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1018907

Antiplasmodial Activity of SAHAquines, Novel SAHA - Primaquine Hybrids


Beus, Maja; Rajić, Zrinka; Mlinarić, Zvonimir; Fontinha, Diana; Prudêncio, Miguel; Held, Jana; Zorc, Branka
Antiplasmodial Activity of SAHAquines, Novel SAHA - Primaquine Hybrids // 6th EFMC Young Medicinal Chemist Symposium ; Book of Abstracts
Atena, Grčka, 2019. str. 26-26 (predavanje, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 1018907 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Antiplasmodial Activity of SAHAquines, Novel SAHA - Primaquine Hybrids

Autori
Beus, Maja ; Rajić, Zrinka ; Mlinarić, Zvonimir ; Fontinha, Diana ; Prudêncio, Miguel ; Held, Jana ; Zorc, Branka

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
6th EFMC Young Medicinal Chemist Symposium ; Book of Abstracts / - , 2019, 26-26

Skup
6th EFMC Young Medicinal Chemist Symposium

Mjesto i datum
Atena, Grčka, 05-06.09.2019

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
malaria ; antiplasmodial activity ; primaquine ; vorinostat ; hybrid drugs

Sažetak
SAHAquines are novel hybrid compounds that combine moieties of suberoylanilide hydroxamic acid (SAHA), an anticancer agent with weak antiplasmodial activity, and primaquine, an antimalarial drug with low antiproliferative activity (1-3). The prepared SAHAquines differ in linker length/type and/or functional groups: compounds 1 are esters, 2 are carboxylic acids, 4 are unsubstituted and 3 and 5 are O-benzyl and O-methyl substituted hydroxamic acids. To evaluate their antiplasmodial activity, SAHAquines were tested in vitro against P. falciparum erythrocytic stages (3D7 and Dd2 strains) and against P. berghei hepatic stages. Overall, our results show that SAHAquines with free hydroxamic acid were the most potent, out of which SAHAquine 4b had the lowest IC50 values (0.4 μM for Pf3D7, 1.9 μM for the PfDd2 strain (erythrocytic stage) and 0.43 μM (hepatic stage)). SAHAquine 1b from the ester subclass was the only compound out of hydroxamic acid series with IC50 values in a low micromolar range. This is probably due to α, β-unsaturated carbonyl group (Michael acceptor moiety), capable of conjugate addition.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Interdisciplinarne prirodne znanosti, Farmacija



POVEZANOST RADA


Projekt / tema
HRZZ-IP-09-2014-1501

Ustanove
Farmaceutsko-biokemijski fakultet, Zagreb

Profili:

Avatar Url Zrinka Rajić (autor)

Avatar Url Maja Beus (autor)

Citiraj ovu publikaciju

Beus, Maja; Rajić, Zrinka; Mlinarić, Zvonimir; Fontinha, Diana; Prudêncio, Miguel; Held, Jana; Zorc, Branka
Antiplasmodial Activity of SAHAquines, Novel SAHA - Primaquine Hybrids // 6th EFMC Young Medicinal Chemist Symposium ; Book of Abstracts
Atena, Grčka, 2019. str. 26-26 (predavanje, međunarodna recenzija, sažetak, znanstveni)
Beus, M., Rajić, Z., Mlinarić, Z., Fontinha, D., Prudêncio, M., Held, J. & Zorc, B. (2019) Antiplasmodial Activity of SAHAquines, Novel SAHA - Primaquine Hybrids. U: 6th EFMC Young Medicinal Chemist Symposium ; Book of Abstracts.
@article{article, year = {2019}, pages = {26-26}, keywords = {malaria, antiplasmodial activity, primaquine, vorinostat, hybrid drugs}, title = {Antiplasmodial Activity of SAHAquines, Novel SAHA - Primaquine Hybrids}, keyword = {malaria, antiplasmodial activity, primaquine, vorinostat, hybrid drugs}, publisherplace = {Atena, Gr\v{c}ka} }




Contrast
Increase Font
Decrease Font
Dyslexic Font